chr16-74682727-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_152649.4(MLKL):c.880C>T(p.Leu294=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00104 in 1,614,104 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0056 ( 10 hom., cov: 31)
Exomes 𝑓: 0.00057 ( 10 hom. )
Consequence
MLKL
NM_152649.4 synonymous
NM_152649.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.935
Genes affected
MLKL (HGNC:26617): (mixed lineage kinase domain like pseudokinase) This gene belongs to the protein kinase superfamily. The encoded protein contains a protein kinase-like domain; however, is thought to be inactive because it lacks several residues required for activity. This protein plays a critical role in tumor necrosis factor (TNF)-induced necroptosis, a programmed cell death process, via interaction with receptor-interacting protein 3 (RIP3), which is a key signaling molecule in necroptosis pathway. Inhibitor studies and knockdown of this gene inhibited TNF-induced necrosis. High levels of this protein and RIP3 are associated with inflammatory bowel disease in children. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 16-74682727-G-A is Benign according to our data. Variant chr16-74682727-G-A is described in ClinVar as [Benign]. Clinvar id is 791336.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.935 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00564 (858/152216) while in subpopulation AFR AF= 0.0199 (825/41526). AF 95% confidence interval is 0.0187. There are 10 homozygotes in gnomad4. There are 393 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 10 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MLKL | NM_152649.4 | c.880C>T | p.Leu294= | synonymous_variant | 6/11 | ENST00000308807.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MLKL | ENST00000308807.12 | c.880C>T | p.Leu294= | synonymous_variant | 6/11 | 2 | NM_152649.4 | P1 | |
MLKL | ENST00000306247.11 | c.536-7323C>T | intron_variant | 1 | |||||
MLKL | ENST00000571303.1 | c.352C>T | p.Leu118= | synonymous_variant, NMD_transcript_variant | 3/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00562 AC: 855AN: 152098Hom.: 10 Cov.: 31
GnomAD3 genomes
AF:
AC:
855
AN:
152098
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00150 AC: 378AN: 251446Hom.: 8 AF XY: 0.000964 AC XY: 131AN XY: 135896
GnomAD3 exomes
AF:
AC:
378
AN:
251446
Hom.:
AF XY:
AC XY:
131
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000566 AC: 827AN: 1461888Hom.: 10 Cov.: 30 AF XY: 0.000468 AC XY: 340AN XY: 727246
GnomAD4 exome
AF:
AC:
827
AN:
1461888
Hom.:
Cov.:
30
AF XY:
AC XY:
340
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00564 AC: 858AN: 152216Hom.: 10 Cov.: 31 AF XY: 0.00528 AC XY: 393AN XY: 74414
GnomAD4 genome
AF:
AC:
858
AN:
152216
Hom.:
Cov.:
31
AF XY:
AC XY:
393
AN XY:
74414
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 18, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at